Want to see HK:9885 full AI Analyst Report?
9885 Stock Chart & Stats
HK$5.16
HK$0.08(1.41%)
At close: 4:00 PM EST
HK$5.16
HK$0.08(1.41%)
Day’s Range― - ―
52-Week RangeHK$2.96 - HK$12.66
Previous CloseN/A
Volume1.48M
Average Volume (3M)9.20M
Market Cap
HK$2.34B
Enterprise ValueHK$2.23B
Total Cash (Recent Filing)HK$3.38B
Total Debt (Recent Filing)HK$2.77B
Price to Earnings (P/E)13.5
Beta0.66
Next Earnings
Aug 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.38%
Share Statistics
EPS (TTM)0.22
Shares Outstanding691,792,300
10 Day Avg. Volume7,414,414
30 Day Avg. Volume9,200,413
Financial Highlights & Ratios
PEG Ratio0.06
Price to Book (P/B)1.37
Price to Sales (P/S)0.16
P/FCF Ratio5.41
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.38
Revenue Forecast (FY)HK$23.42B
Bulls Say, Bears Say
Bulls Say
Strong Free Cash Flow GenerationConsistently positive operating and free cash flow, with ~27% FCF growth in 2025, indicates durable internal funding for operations, capex, dividends or M&A. Alignment of FCF with reported profits supports earnings credibility and reduces reliance on external financing over the medium term.
Revenue Growth And Return To ProfitabilitySteady top-line growth plus an inflection to positive EBIT and net income in 2025 signal improving business scale and operational leverage. This structural shift from losses to profitability supports sustainable earnings generation and reinvestment capacity over the coming quarters.
Balance-sheet Recovery And Positive EquityRestored positive equity and a modest positive ROE indicate improved solvency versus prior years of negative equity. Stronger equity provides a buffer against shocks, enhances creditor confidence and preserves strategic flexibility for investments or shareholder returns in the medium term.
Bears Say
Very Thin Gross And Net MarginsGross margin around 11% and net margin under 1% are unusually low for an application software firm, leaving limited room to absorb cost inflation, invest in R&D or discounting. Small adverse changes in cost or pricing could materially erode profits, challenging margin durability.
Rising Leverage And Higher Debt LoadA sharp rise in debt and debt-to-equity near 1.13 increases interest and refinancing risk and constrains capital allocation. Higher leverage limits tactical responses to shocks, raises fixed costs, and can amplify earnings volatility if growth or cash conversion weakens.
Low Cash Conversion Relative To RevenueDespite positive absolute cash flow, low operating cash flow relative to sales means revenue growth may not reliably translate to proportionate cash. This weak cash conversion heightens sensitivity to working-capital swings and could strain liquidity if revenue growth slows or receivables lengthen.
YSB Inc. News
9885 FAQ
What was YSB Inc.’s price range in the past 12 months?
YSB Inc. lowest stock price was HK$2.96 and its highest was HK$12.66 in the past 12 months.
What is YSB Inc.’s market cap?
YSB Inc.’s market cap is HK$2.34B.
When is YSB Inc.’s upcoming earnings report date?
YSB Inc.’s upcoming earnings report date is Aug 18, 2026 which is in 33 days.
How were YSB Inc.’s earnings last quarter?
YSB Inc. released its earnings results on Mar 23, 2026. The company reported HK$0.122 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.122.
Is YSB Inc. overvalued?
According to Wall Street analysts YSB Inc.’s price is currently Overvalued.
Does YSB Inc. pay dividends?
YSB Inc. pays a Notavailable dividend of HK$0.125 which represents an annual dividend yield of 1.38%. See more information on YSB Inc. dividends here
What is YSB Inc.’s EPS estimate?
YSB Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does YSB Inc. have?
YSB Inc. has 691,792,300 shares outstanding.
What happened to YSB Inc.’s price movement after its last earnings report?
YSB Inc. reported an EPS of HK$0.122 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -5.088%.
Which hedge fund is a major shareholder of YSB Inc.?
Currently, no hedge funds are holding shares in HK:9885
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
YSB Inc. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
11.66%
12-Months-Change
Fundamentals
Return on Equity
6.41%
Trailing 12-Months
Asset Growth
21.86%
Trailing 12-Months
Company Description
YSB Inc.
YSB Inc. provides a comprehensive digital platform tailored for the Chinese pharmaceutical sector, supporting a wide array of stakeholders such as drug companies, distributors, vendors, pharmacies, and primary healthcare facilities. Its key offerings feature ClouDiagnos, a specialized diagnostic testing service; wePharmacy, an intelligent, unmanned pharmaceutical booth accessible 24/7 that facilitates connections between customers and professional pharmacist services; a suite of Software-as-a-Service (SaaS) solutions; and YSB eLearn, which delivers online courses to prepare individuals for pharmacist qualification examinations. Beyond its digital offerings, the company engages in the wholesale and retail distribution of pharmaceutical and healthcare merchandise, and additionally provides medical testing services. The company was established in 2015 and is headquartered in Guangzhou, China.
Technical Analysis
China Youzan
―
Kingdee International Software Group Co
―
Weimob
―
Chanjet Information Technology Co., Ltd. Class H
―
Baiwang Co., Ltd. Class H
―